News
LFMD
3.259
-3.59%
-0.121
Weekly Report: what happened at LFMD last week (0803-0807)?
Weekly Report · 2d ago
LifeMD price target lowered to $5 from $8 at KeyBanc
TipRanks · 4d ago
LifeMD Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 5d ago
LifeMD Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co.
Dow Jones · 5d ago
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9
Benzinga · 5d ago
LifeMD price target lowered to $9 from $10 at H.C. Wainwright
TipRanks · 5d ago
LifeMD Is Maintained at Buy by B. Riley Securities
Dow Jones · 6d ago
LifeMD price target lowered to $8 from $10 at B. Riley
TipRanks · 6d ago
Cantor Fitzgerald Remains a Buy on LifeMD (LFMD)
TipRanks · 6d ago
LifeMD price target lowered to $7 from $8 at Mizuho
TipRanks · 6d ago
LifeMD price target lowered to $9 from $10 at BTIG
TipRanks · 6d ago
LifeMD Is Maintained at Buy by BTIG
Dow Jones · 6d ago
LifeMD Price Target Cut to $9.00/Share From $10.00 by BTIG
Dow Jones · 6d ago
BTIG Maintains Buy on LifeMD, Lowers Price Target to $9
Benzinga · 6d ago
LifeMD sees Q3 revenue $48M-$51M, consensus $58.55M
TipRanks · 6d ago
LifeMD Updates Q2 Results and Subscription Growth Outlook
TipRanks · 6d ago
UPDATE - LifeMD Reports Second Quarter 2026 Results
Barchart · 6d ago
Weekly Report: what happened at LFMD last week (0727-0731)?
Weekly Report · 08/03 09:20
Weekly Report: what happened at LFMD last week (0720-0724)?
Weekly Report · 07/27 09:21
Weekly Report: what happened at LFMD last week (0713-0717)?
Weekly Report · 07/20 09:20
More
Webull provides a variety of real-time LFMD stock news. You can receive the latest news about Lifemd Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFMD
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.